T45.1X4 Категория · требуется уточнение Poisoning by antineoplastic and immunosuppressive drugs, undetermined

ICD-10-CM T45.1X4 identifies “Poisoning by antineoplastic and immunosuppressive drugs, undetermined” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Глава 19: Injury, poisoning and certain other consequences of external causes

Инструкции к коду

Дополнительных примечаний нет.

Инструкции вышестоящих уровней

Главы 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)

Excludes 22
  • birth trauma (P10-P15)
  • obstetric trauma (O70-O71)
Use additional code1

code to identify any retained foreign body, if applicable (Z18.-)

Note2
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.

T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)

Includes4
  • adverse effect of correct substance properly administered
  • poisoning by overdose of substance
  • poisoning by wrong substance given or taken in error
  • underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11

toxic reaction to local anesthesia in pregnancy (O29.3-)

Excludes 25
  • abuse and dependence of psychoactive substances (F10-F19)
  • abuse of non-dependence-producing substances (F55.-)
  • immunodeficiency due to drugs (D84.821)
  • drug reaction and poisoning affecting newborn (P00-P96)
  • pathological drug intoxication (inebriation) (F10-F19)
Code first7
  • , for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)
Use additional code4
  • code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
  • underdosing of medication regimen (Z91.12-, Z91.13-)
Note1

The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.

T45 · Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified

Seventh character1

The appropriate 7th character is to be added to each code from category T45

A — initial encounter

D — subsequent encounter

S — sequela

T45.1 · Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs

Excludes 12
  • poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs (T45.A)
  • poisoning by, adverse effect of and underdosing of tamoxifen (T38.6)

Более конкретные коды

Ссылки в официальном указателе

Ссылки в официальном указателе (183)

2-Deoxy-5-fluorouridine (1)
5-Deoxy-5-fluorouridine (1)
Aclarubicin (1)
Actinomycin C (1)
Actinomycin D (1)
Adriamycin (1)
Alkylating drug NEC (3)
Altretamine (1)
Amethopterin (1)
Aminoglutethimide (1)
Aminopterin sodium (1)
Amsacrine (1)
Antagonist (2)
Anthramycin (1)
Antibiotic NEC (2)
Anticancer agents NEC (1)
Antimetabolite (1)
Antimitotic agent (1)
Antineoplastic NEC (4)
Ara-C (1)
Asparaginase (1)
Azacitidine (1)
Azaribine (1)
Azaserine (1)
Azatepa (1)
Azathioprine (1)
BCNU (1)
Benzcarbimine (1)
Bleomycin (1)
Broxuridine (1)
Busulfan, busulphan (1)
Cactinomycin (1)
Cancer chemotherapy drug regimen (1)
Carboplatin (1)
Carboquone (1)
Carmofur (1)
Carmustine (1)
Chlorambucil (1)
Chlorhexamide (1)
Chlormethine (1)
Chloropurine (1)
Chromic (1)
Chromomycin A3 (1)
Ciclosporin (1)
Cisplatin (1)
Colaspase (1)
Corynebacterium parvum (1)
Cycloleucin (1)
Cyclophosphamide (1)
Cyclosporin (1)
Cytarabine (1)
Cytosine arabinoside (1)
Cytoxan (1)
Dacarbazine (1)
Dactinomycin (1)
Daunomycin (1)
Daunorubicin (1)
Demecolcine (1)
Dibromodulcitol (1)
Dibromomannitol (1)
Doxifluridine (1)
Doxorubicin (1)
DTIC (1)
Elliptinium acetate (1)
Enocitabine (1)
Epirubicin (1)
Estramustine (1)
Ethyl (1)
Etoglucid (1)
Etoposide (1)
FAC(fluorouracil + doxorubicin + cyclophosphamide) (1)
Floxuridine (1)
Fluorodeoxyuridine (1)
Fluorouracil (1)
Folic acid (1)
Ftorafur (1)
Gold (1)
Goserelin (1)
Hexamethylmelamine (1)
Hormone (1)
Hydroxycarbamide (1)
Hydroxyurea (1)
Idarubicin (1)
Ifosfamide (1)
Imidazole-4-carboxamide (1)
Immunosuppressive drug (1)
Inproquone (1)
Iproplatin (1)
Isophosphamide (1)
Leukeran (1)
Lomustine (1)
Lonidamine (1)
M-AMSA (1)
M-vac (1)
Mannomustine (1)
Matulane (1)
Mechlorethamine (1)
Melphalan (1)
Mercaptopurine (1)
Methotrexate (1)
Methyl (1)
Metoprine (1)
Mithramycin (1)
Mitobronitol (1)
Mitoguazone (1)
Mitolactol (1)
Mitomycin (1)
Mitopodozide (1)
Mitotane (1)
Mitoxantrone (1)
Mopidamol (1)
MOPP(mechlorethamine + vincristine + prednisone + procarbazine) (1)
Muromonab-CD3 (1)
Mustard(emetic) (1)
Mustine (1)
Myelobromal (1)
Myleran (1)
Nimustine (1)
Nitrogen (1)
Olivomycin (1)
Oncovin (1)
Paroxypropione (1)
Pentostatin (1)
Peplomycin (1)
Phenyl (1)
Phenylalanine mustard (1)
Pipobroman (1)
Pirarubicin (1)
Plicamycin (1)
Porfiromycin (1)
Prednimustine (1)
Procarbazine (1)
Pteroyltriglutamate (1)
Purine analogue(antineoplastic) (1)
Purinethol (1)
Pyrimidine antagonist (1)
Razoxane (1)
Rubidomycin (1)
Rufocromomycin (1)
Sarcolysin (1)
Sarkomycin (1)
Semustine (1)
Sodium (1)
Streptozocin (1)
Streptozotocin (1)
Tauromustine (1)
Tegafur (1)
TEM (1)
Teniposide (1)
TEPA (1)
Thalidomide (1)
Thioguanine (1)
Thiotepa (1)
Tioguanine (1)
Treosulfan (1)
Tretamine (1)
Triaziquone (1)
Trichlormethine (1)
Trichlorotriethylamine (1)
Triethanomelamine (1)
Triethylenemelamine (1)
Triethylenephosphoramide (1)
Triethylenethiophosphoramide (1)
Trimetrexate (1)
Trimustine (1)
Trofosfamide (1)
Uracil mustard (1)
Uramustine (1)
Urethane (1)
Vinblastine (1)
Vincamine (1)
Vincristine (1)
Vindesine (1)
Vinorelbine tartrate (1)
Zinostatin (1)
Zorubicin (1)
История

История кода

Последнее зарегистрированное изменение · FY2025 · 04-01

ИзменёнБез изменений
FY2025 · 04-01

Действует с

  • Изменены унаследованные указания

Poisoning by antineoplastic and immunosuppressive drugs, undetermined

Категория — выберите более точный код

CDC/NCHS · FY2025 · 04-01

Все версии (19)

Все версииДействует сИстория кода
FY20162015-10-01Первое наблюдение
FY20172016-10-01Без изменений в таблице
FY20182017-10-01Без изменений в таблице
FY20192018-10-01Изменены унаследованные указания
FY20202019-10-01Без изменений в таблице
FY2020 · April2020-04-01Без изменений в таблице
FY20212020-10-01Изменены унаследованные указания
FY2021 · 01-012021-01-01Без изменений в таблице
FY20222021-10-01Без изменений в таблице
FY2022 · 04-012022-04-01Без изменений в таблице
FY20232022-10-01Без изменений в таблице
FY2023 · 04-012023-04-01Без изменений в таблице
FY20242023-10-01Без изменений в таблице
FY2024 · 04-012024-04-01Без изменений в таблице
FY20252024-10-01Изменены унаследованные указания
FY2025 · 04-012025-04-01Изменены унаследованные указания
FY20262025-10-01Без изменений в таблице
FY2026 · April2026-04-01Без изменений в таблице
FY20272026-10-01Без изменений в таблице

Изучите более конкретные коды этой категории. Проверка по справочнику не подтверждает клиническую обоснованность и не гарантирует возмещение.